SAN FRANCISCO, Oct. 05, 2016 -- Hagens Berman Sobol Shapiro LLP reminds investors in Polaris Industries Inc. (NYSE:PII) of the November 15, 2016 Lead Plaintiff deadline in the securities class action lawsuit filed in the United States District Court for the District of Minnesota.
If you purchased or otherwise acquired securities of PII between January 26, 2016 and September 11, 2016 and suffered over $50,000 in losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/PII
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing [email protected].
Between July 2015 and April 2016, Polaris announced four recalls for numerous of its off-road vehicles due to “thermal-related incidents” such as fires. In July 2016, Polaris issued a stop-ride/stop-sale advisory pending the recall of another vehicle, again citing fire hazards.
Throughout the recall announcements, Polaris on numerous occasions disclosed fiscal year 2016 net income guidance of $6.00 per share.
On September 12, 2016, less than two months after Polaris last provided its $6.00 per share earnings guidance, the Company abruptly slashed guidance to $3.30 - $3.80 per share, citing vehicle fire hazards as the reason for reduced earnings. In response, Polaris stock fell approximately 5% to close at $76.79 on September 12th and continued to decline throughout the week.
SEC filings show that Polaris’ CFO and the President of Polaris’ Off-Road Vehicles together sold over $2,700,000 of Company stock between January and August 2016.
“Defendants apparently were aware of the fire hazards associated with certain of Polaris’ vehicles for over a year,” said Hagens Berman partner Reed Kathrein. “We’re looking at why Defendants waited so long to reduce earnings guidance.”
Whistleblowers: Persons with non-public information regarding Polaris Industries should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email. [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. Read the Firm’s Securities Newsletter, and visit the blog. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000


Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 



